Omics · study · 2026
Prolonged methionine restriction induces liver cancer persistence
Listed in NCBI GEO
Methionine restriction (MR) has been shown to inhibit cancer cell growth and enhance cancer therapy.
Description
However, its long-term impact on cancer progression remains unknown. Here we report that prolonged methionine restriction in epithelial human liver cancer cells leads to the formation of drug-tolerant persisters.
Epithelial human HCC cells, such as HepG2 and Huh7 cells, could survive prolonged methionine restriction. The surviving cells display typical characteristics of persistent cancer cells, including slow proliferation, diminished protein synthesis, gain of mesenchymal features, and resistance to chemotherapy. RNA-seq analysis reveals that MR persisters have increased expression of genes mediating cell migration, inflammation, and stress response, yet reduced abundance of genes involved in cell cycle regulation, metabolism, detoxification, and translation.
Read the rest (1 more)
These transformations closely resemble those previously observed in liver cancer cells knocked down hepatocyte nuclear factor 4 (HNF4), suggesting that the formation of persistent liver cancer cells may be coupled with diminished HNF4 activity. In support of this possibility, genes altered in MR persisters significantly overlapped with those changed by HNF4 knockdown. Moreover, about 40% of downregulated genes shared by both HepG2 and Huh7 MR persister cells have been previously identified as HNF4 target genes.
Links
Get the data
- GEO FTP directory ftp.ncbi.nlm.nih.gov/geo/series/GSE314nnn/GSE314964 ↗
download · from NCBI GEO
Where it is published
- GEO accession page ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314964 ↗
landing page · from NCBI GEO
Documentation and papers
- PRJNA1393367 ncbi.nlm.nih.gov/bioproject/PRJNA1393367 ↗
project · from NCBI GEO
Topics
- Stated by source
- Expression profiling by high throughput sequencing · Homo sapiens
- From keywords
- Life Sciences
- Inferred from text
- Cancer 75% · RNA sequencing 65%
Provenance · 1 source records, 9 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| NCBI GEO | GSE314964 | 14 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[disease].local:disease:cancer | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[field].local:field:life-sciences | mapping · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencing | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /gdstype |
| concepts[modality].local:modality:rna-seq | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (65%) |
| concepts[organism].NCBITaxon:9606 | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /taxon |
| description | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /summary |
| publication_date | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| title | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /title |